MANTADIX 100 mg, capsule 50 capsules, CIP 3400930235942
Active ingredients: Amantadine hydrochloride
Commercialized according to BDPMDispensing in France: Prescription only
Capsule50 capsules, CIP 3400930235942orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- MANTADIX 100 mg, capsule
- Pharmaceutical form
- capsule
- Route of administration
- orale
- Presentation description
- plaquette(s) aluminium PVC polyéthylène PVDC de 50 capsule(s)
- Marketing authorisation holder
- LABORATOIRE XO
- Reimbursement according to BDPM
- 30%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Apr 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
67703803CIP73023594CIP133400930235942Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE D'AMANTADINEcapsule | 100 mg · une capsule | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.